Comparison of urine and serum IgG detection ELISA for tegumentary leishmaniasis diagnosis and prognosis
Raquel S.B. Câmara,Isabela A.G. Pereira,Daniela P. Lage,Danniele L. Vale,Fernanda Ludolf,Nathália C. Galvani,Camila S. Freitas,João A. Oliveira-da-Silva,Bárbara P.N. Assis,Ana T. Chaves,Mário S. Giusta,Grasiele S.V. Tavares,César N. Pereira,Alexsandro S. Galdino,Unaí Tupinambás,Miguel A. Chávez-Fumagalli,Vanessa P.M. Pascoal,Marcela T.C. Eller,Manoel O. da Costa Rocha,Myron Christodoulides,Ricardo A. Machado-de-Ávila,Denise U. Gonçalves,Eduardo A.F. Coelho
DOI: https://doi.org/10.1016/j.imbio.2024.152853
IF: 3.152
2024-09-19
Immunobiology
Abstract:Laboratorial diagnosis of tegumentary leishmaniasis (TL) is hampered by variable sensitivity and/or specificity of the tests, which are still hampered by blood́ invasive collection. In this context, in the present study, we develop a serum- and urine-based ELISA to TL diagnoses. A recombinant protein (rLiHyA), which was previously showed to be antigenic for the disease, as well as a B-cell epitope produced as synthetic peptide and a Leishmania antigenic extract (SLA), were used as antigens. A total of paired 205 urine and serum samples were used, which were comprised by samples from cutaneous (n = 30) and mucosal (n = 30) leishmaniasis patients, as well as from healthy individuals living in endemic region of disease (n = 45), of patients with Chagas disease (n = 30), leprosy (n = 35), malaria (n = 15) or HIV-infected (n = 20). Results showed that serum-based ELISA presented sensitivity of 24.0 %, 100 % and 41.0 %, when SLA, rLiHyA and synthetic peptide were used as antigens, and specificity of 98.4 %, 98.4 % and 98.4 %, respectively. The area under the curve (AUC) was calculated and results were 0.74, 1.0, and 0.71, respectively, when SLA, rLiHyA and synthetic peptide were used as antigens. Performing an urine-based ELISA, sensitivity was 28.0 %, 100 % and 75.0 %, respectively, when SLA, rLiHyA, and synthetic peptide were used, while specificity values were of 98.4 %, 98.4 % and 98.4 %, respectively. In addition, the AUC values were 0.82, 1.0, and 0.94, respectively. A significant drop in specific antibodies levels in both patientś serum and urine samples was found six months after treatment, suggesting a prognostic role of rLiHyA for TL. In conclusion, preliminary data suggest the potential of use patient urine to TL diagnoses.
immunology